Posts

Showing posts with the label favimol

Pharmacology of Favimol

Image
 Favipiravir (T-705) is an engineered prodrug, first found while evaluating the antiviral action of substance specialists dynamic against the flu infection in the compound library of Toyoma synthetics. A lead compound, A/PR/8/34, later assigned as T-1105, and its subordinates were found to have antiviral exercises. Favipiravir is determined by synthetic alteration of the pyrazine moiety of T-1105 (Fig. 1).2 It has been affirmed in Japan for the administration of arising pandemic flu contaminations in 2014.